股本结构
单位：万股
| 公告日期 | 2025-11-13 | 2025-08-13 | 2025-05-13 | 2025-05-13 | 2025-03-04 | 2024-11-13 |
|---|---|---|---|---|---|---|
| 证券总股本 | 678.20 | 675.07 | 655.99 | 655.89 | 652.59 | 652.53 |
| 普通股本 | 678.20 | 675.07 | 655.99 | 655.89 | 652.59 | 652.53 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-09-30 | 2025-06-30 | 2025-05-09 | 2025-03-31 | 2024-11-11 | 2024-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-13 | 678.20 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock upon exercise of stock options
|
2025-09-30 |
| 2025-08-13 | 675.07 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock in at-the-market offering, net of $0.3 million in issuance costs
|
2025-06-30 |
| 2025-05-13 | 655.99 | 未披露 | 定期报告 | 2025-05-09 |
| 2025-05-13 | 655.89 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Shares of common stock issued in connection with incentive stock plan
|
2025-03-31 |
| 2025-03-04 | 652.59 | 未披露 | 定期报告 | 2024-11-11 |
| 2024-11-13 | 652.53 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Shares of common stock issued in connection with incentive stock plan
|
2024-09-30 |
| 2024-03-21 | 650.39 | 未披露 | 定期报告 | 2023-12-31 |
| 2023-12-05 | 650.00 | 未披露 |
更多>>
Instil Bio, Inc. announced that a 1-for-20 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Thursday, December 7, 2023.
|
2023-12-08 |
| 2023-05-11 | 13007.91 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-31 | 13007.91 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Shares of common stock issued in connection with incentive stock plan
|
2022-12-31 |
| 2022-11-14 | 12977.51 | 未披露 | 定期报告 | 2022-11-10 |
| 2022-11-14 | 12975.37 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Shares of common stock issued in connection with incentive stock plan
|
2022-09-30 |
| 2022-08-12 | 12969.44 | 未披露 | 定期报告 | 2022-08-10 |
| 2022-08-12 | 12955.03 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Shares of common stock issued in connection with incentive stock plan
|
2022-06-30 |
| 2022-05-16 | 12929.35 | 未披露 | 定期报告 | 2022-05-12 |
| 2022-05-16 | 12921.79 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Shares of common stock issued in connection with incentive stock plan
|
2022-03-31 |
| 2022-03-30 | 12918.33 | 未披露 | 定期报告 | 2022-03-28 |
| 2022-03-07 | 12913.00 | 未披露 | 定期报告 | 2022-03-03 |
| 2022-03-07 | 12902.83 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of Series C convertible preferred shares at $12.58 per share
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs
Conversion of redeemable convertible preferred stock
Issuance of common stock from exercises of stock options
|
2021-12-31 |
| 2021-11-15 | 12892.68 | 未披露 | 定期报告 | 2021-11-12 |
| 2021-11-15 | 12885.73 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock from exercises of stock options
|
2021-09-30 |
| 2021-08-12 | 12876.19 | 未披露 | 定期报告 | 2021-08-10 |
| 2021-05-13 | 12874.31 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of Series C convertible preferred shares at $12.58 per share
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs
Conversion of redeemable convertible preferred stock
Shares of common stock issued in connection with incentive stock plan
|
2021-03-31 |
| 2021-05-13 | 12821.23 | 未披露 |
更多>>
1. On March 23, 2021, Instil closed its initial public offering of 18,400,000 shares of common stock, including the full exercise of the underwriters’ option to purchase an additional 2,400,000 shares of common stock at the public offering price of $20.00 per share.
2.The number of shares of common stock to be outstanding after this offering is based on 109,812,253 shares of common stock outstanding as of December 31, 2020, after giving effect to the automatic conversion of all outstanding shares of convertible preferred stock into an aggregate of 89,220,699 shares of common stock upon the closing of this offering
|
2021-03-23 |
| 2021-03-22 | 12581.23 | 未披露 |
更多>>
1.Common stock offered by the company 16,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 109,812,253 shares of common stock outstanding as of December 31, 2020, after giving effect to the automatic conversion of all outstanding shares of convertible preferred stock into an aggregate of 89,220,699 shares of common stock upon the closing of this offering
|
2021-03-19 |
From June 30, 2025 to September 30, 2025
Issuance of common stock upon exercise of stock options
From March 31, 2025 to June 30, 2025
Issuance of common stock upon exercise of stock options
Issuance of common stock in at-the-market offering, net of $0.3 million in issuance costs
From December 31, 2024 to March 31, 2025
Shares of common stock issued in connection with incentive stock plan
From June 30, 2024 to September 30, 2024
Shares of common stock issued in connection with incentive stock plan
Instil Bio, Inc. announced that a 1-for-20 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Thursday, December 7, 2023.
From December 31, 2021 to December 31, 2022
Shares of common stock issued in connection with incentive stock plan
From June 30, 2022 to September 30, 2022
Shares of common stock issued in connection with incentive stock plan
From March 31, 2022 to June 30, 2022
Shares of common stock issued in connection with incentive stock plan
From December 31, 2021 to March 31, 2022
Shares of common stock issued in connection with incentive stock plan
From December 31, 2020 to December 31, 2021
Issuance of Series C convertible preferred shares at $12.58 per share
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs
Conversion of redeemable convertible preferred stock
Issuance of common stock from exercises of stock options
From June 30, 2021 to September 30, 2021
Issuance of common stock from exercises of stock options
From December 31, 2020 To March 31, 2021
Issuance of Series C convertible preferred shares at $12.58 per share
Issuance of common shares upon initial public offering net of underwriting discounts, commissions and offering costs
Conversion of redeemable convertible preferred stock
Shares of common stock issued in connection with incentive stock plan
1. On March 23, 2021, Instil closed its initial public offering of 18,400,000 shares of common stock, including the full exercise of the underwriters’ option to purchase an additional 2,400,000 shares of common stock at the public offering price of $20.00 per share.
2.The number of shares of common stock to be outstanding after this offering is based on 109,812,253 shares of common stock outstanding as of December 31, 2020, after giving effect to the automatic conversion of all outstanding shares of convertible preferred stock into an aggregate of 89,220,699 shares of common stock upon the closing of this offering
1.Common stock offered by the company 16,000,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 109,812,253 shares of common stock outstanding as of December 31, 2020, after giving effect to the automatic conversion of all outstanding shares of convertible preferred stock into an aggregate of 89,220,699 shares of common stock upon the closing of this offering